Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InnovAge HoldingINNV -2.03%60 Receivables Turnover is 10.10 as of Mar. 2026. GuruFocus rates INNV with a GF Score™ of 60/100 and a GF Value™ of $6.57 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 658 Healthcare Providers & Services companies, InnovAge Holding ranks better than 89.82% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. InnovAge Holding's Revenue for the
three
months ended in Mar. 2026 was $251.9 Mil. InnovAge Holding's average Accounts Receivable for the
three
months ended in Mar. 2026 was $24.9 Mil.
Hence, InnovAge Holding's Receivables Turnover for the
three
months ended in Mar. 2026 was 10.10.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
InnovAge Holding Receivables Turnover Related Terms
InnovAge Holding Receivables Turnover Historical Data
* Premium members only.
The historical data trend for InnovAge Holding's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INNV vs HCSG, ARDT, AGL: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, InnovAge Holding's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnovAge Holding Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where InnovAge Holding's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnovAge Holding (INNV) has a Receivables Turnover of 10.10 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on InnovAge Holding and its competitors. According to the industry distribution chart, InnovAge Holding ranks #67 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 10.2%.
Is InnovAge Holding's Receivables Turnover too high?
InnovAge Holding's current Receivables Turnover is 10.10. The Healthcare Providers & Services industry median Receivables Turnover is 7.73. InnovAge Holding's value of 10.10 is 30.7% above this industry median. Based on the distribution chart, InnovAge Holding ranks #67 out of 658 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, InnovAge Holding has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnovAge Holding's Receivables Turnover compare to HCSG and ARDT?
According to the Healthcare Providers & Services industry distribution chart, InnovAge Holding ranks #67 out of 658 companies for Receivables Turnover. This places InnovAge Holding in the top 10% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.73. InnovAge Holding's value of 10.10 is 30.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.73, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnovAge Holding's current Receivables Turnover of 10.10 is 30.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on InnovAge Holding and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnovAge Holding's current Receivables Turnover is 10.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnovAge Holding stock overvalued right now?
Based on GuruFocus' analysis, InnovAge Holding (INNV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.57, compared to a current price of $11.34 — trading 72.6% above its estimated fair value. The current Receivables Turnover is 10.10 and 30.7% above the Healthcare Providers & Services industry median of 7.73. InnovAge Holding's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For InnovAge Holding (INNV), the current Receivables Turnover is 10.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnovAge Holding (INNV) Overvalued in 2026?
Based on GuruFocus' analysis, InnovAge Holding stock appears to be overvalued.
The current stock price of $11.34 is trading 72.6% above its estimated GF Value™ of $6.57.
GuruFocus considers InnovAge Holding to be Significantly Overvalued.
Key valuation signals for INNV:
Receivables Turnover: 10.10
GF Value™: $6.57 vs. price of $11.34 (72.6% above fair value)
Industry Position: 30.7% above the Healthcare Providers & Services median (#67 of 658)
No single metric tells the full story. See the INNV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
60GF Score
Get the complete analysis for INNV
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INNV has been successfully added to your 
